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Fig 1. The traditional metric for predicting arteriovenous ﬁstula (AVF)
success failed to correlate with postoperative size at the point of assay.
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Adipose Phenotype Predicts Human Arteriovenous Fistula
Remodelingy
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Objectives: Large proportions of hemodialysis arteriovenous ﬁstulas
(AVFs) fail to mature for unclear reasons. These constructions develop in
a large mass of surrounding adipose tissue that increasingly is recognized
as an active vascular response to injury participant via paracrine/endocrine
mechanisms. We thus hypothesized that baseline phenotypic characteristics
of the adipose juxtaposed to the developing AVF would be associated with
subsequent inward or outward vein wall remodeling.
Methods: Clinical data and subcutaneous adipose tissue were
collected from 22 consented patients undergoing AVF creation. Tissue
was assayed (protein levels) for interleukin (IL)-6, IL-8, leptin, tumor ne-
crosis factor (TNF)-a, monocyte chemotactic protein (MCP)-1, resistin,
and adiponectin. Duplex ultrasound vein dimensions were acquired preop-
eratively and at a single point 1 cm cephalad to the arteriovenous anasto-
mosis (most common location of AVF stenosis) at 4 to 6 weeks
postoperatively.
Results: The Table describes the cohort. The vein at the assayed loca-
tion outwardly remodeled 22% on average (range, 3.66 0.2-5.66 0.5 mm;
P ¼ .005). The traditional metric for predicting AVF success (preoperative
vein diameter) failed to correlate with postoperative size at the point of assay
(R ¼ 0.31, P ¼ .155; Fig 1). Conversely, the correlation coefﬁcients be-
tween venous diameter change (preoperative vs postoperative) and IL-8,
TNF-a, MCP-1, resistin, and adiponectin were e0.49, e0.79, e0.66,
e0.64, and e0.69 respectively (P < .05; Fig 2). Postoperative AVF ﬂow
volume correlated with MCP-1 (e0.53, P < .05) and adiponectin
(e0.47, P < .05).Table. Demographic and clinical data
Characteristic No. (%) (N ¼ 22)
BMI, kg/m2 29.4 6 7.3
Age, years 66.8 6 13.0
Male gender 17 (77.3)
Ethnicity
White, non-Hispanic 11 (50.0)
Hispanic 3 (13.6)
Black 6 (27.3)
Asian 2 (9.1)
Procedure
Radial-cephalic 8 (36.4)
Brachial-cephalic 12 (54.6)
Brachial-basilic 2 (9.1)
Comorbidities
Diabetes mellitus 17 (77.3)
Hypertension 20 (90.9)
Any h/o tobacco use 15 (68.2)
Medications
b-Blocker 18 (81.8)
Calcium channel blocker 15 (68.2)
ACEI 11 (50.0)
ARB 11 (50.0)
a-Agonist 10 (45.5)
Nitrate 15 (68.2)
Diuretic 15 (68.2)
Acetylsalicylic acid 17 (77.3)
Warfarin 11 (50.0)
Clopidogrel 11 (50.0)
Statin 19 (86.4)
ACEI, Angiotensin-converting enzyme inhibitor; ARB, angiotensin recep-
tor blocker; BMI, body mass index; h/o, history of.
Fig 2. Correlation coefﬁcient between venous diameter change and inter-
leukin (IL)-8, tumor necrosis factor (TNF)-a, monocyte chemotactant
protein (MCP)-1, resistin, and adiponectin.
yNew England Society for Vascular SurgeryConclusions: These striking results point to a previously undescribed
relationship between local adipose phenotype and the eventual venous wall
response to hemodynamic perturbation in humans. The predictive value of
these adipokines exceeded that of preoperative vein size. Beyond providing
mechanistic insights into vascular wall adaptations due to ﬂow perturba-
tions, this discovery suggests that strategies focused on altering adipose tis-
sue biology may enhance AVF maturation.
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ness of complete endovascular zone 0 thoracic endovascular aortic repair
(TEVAR) with triple chimneys to the innominate, left carotid, and left sub-
clavian arteries for treatment of complex thoracic arch aneurysms and
dissections.
Methods: This prospective pilot study analyzed initial outcomes
in 15 thoracic arch chimneys to the innominate, left carotid, and left
subclavian arteries and TEVAR with the proximal stent graft landing
zone in the ascending thoracic aorta, zone 0, using off-the-shelf stent
grafts. All TEVAR procedures were performed with a transfemoral
approach; the innominate and left subclavian chimneys were performed
via a transaxillary cut-down approach, and left carotid chimney was per-
formed via carotid cutdown approach. All chimneys were reinforced
with Wallstents. Of the ﬁve initial patients, four (80%) had thoracic dis-
sections involving the arch, and one (20%) had a thoracic arch aneurysm,
and all patients were considered high risk for open surgical repair. The
minimal overlap between the thoracic stent graft and the chimneys
was 6 cm.
Results: Technical success in thoracic aortic dissection and aneu-
rysm exclusion and innominate, carotid, and subclavian perfusion was
achieved in 100% of patients. One high-risk patient with ruptured/symp-
tomatic thoracic arch aneurysm developed cardiac tamponade during the
procedure, which required a pericardial window for drainage, and a
basilar stroke; the family withdrew care and the patient died. Amongst
the four survivors (80%), at a mean follow-up of 6 months, all 12
(100%) of chimneys have remained patent, and there are no identiﬁable
endoleaks.
Conclusions: Initial experience with complete endovascular zone
0 TEVAR and triple chimney technique in select high-risk patients is prom-
ising. To avoid procedure-related complications, vigilance is needed while
orchestrating the operating room setup, establishing chimney overlap, and
stent graft delivery.
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Acoustic Shadowing Signiﬁcantly Impairs Accurate Characterization of
Stenosis in Carotid Duplex Examinationsy
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Objectives: Duplex ultrasonography (DUS) has been the mainstay for
diagnosing carotid artery stenosis and is often the sole methodology con-
ﬁrming a severe stenosis before surgical correction is undertaken. However,
in the presence of highly calciﬁed plaque resulting in an acoustic shadow
(AcS), it is unknown whether DUS, as a result of limited vessel interroga-
tion, can still accurately assess the degree of stenosis.
Methods: From July 2012 to December 2013, all patients with an
AcS measuring $5 mm in the longitudinal axis on DUS were cross-refer-
enced with concomitant neck computed tomographic angiography (CTA)
studies to deﬁne the study population. After standardizing the CTA win-
dows, the degree of stenosis (mild #50%, moderate 51%-69%, severe
$70%) was determined by computerized cross-sectional area measurements
at the point of maximal stenosis within the AcS and, when present, outside
the AcS. DUS parameters distal to the AcS were compared with the CTA
(gold standard) to determine the adequacy of the DUS assessment of ca-
rotid disease severity.
Results: During this period, 8517 DUS studies were performed, 550
of which had AcS (incidence, 6.1%). There were 92 lesions with aTable. Comparison of mean estimated risk generated by the Universal Risk Cal
Occurrence Death Any complication Pneumonia
Card
(arrest o
Estimated risk, % 3.06 15.91 1.84 2.0
Observed outcomes, % 2.79 21.73 2.79 4.4
Brier score 0.03 0.16 0.02 0.0
MI, Myocardial infarction; OR, operating room; SSI, surgical site infection; UTI
yNew England Society for Vascular Surgeryconcomitant CTA that identiﬁed 68 severe, 21 moderate, and three
mild stenoses in this patient cohort with AcS. Of the 68 CTA showing se-
vere stenoses, DUS also identiﬁed severe stenosis in 14 just distal to the
AcS and ﬁve in a remote area. This resulted in an overall sensitivity of
27% (95% conﬁdence interval, 0.175-0.392) for DUS in the presence of
AcS. Univariate analysis revealed no association between peak systolic ve-
locity-determined degree of stenosis and CTA-determined stenosis (P ¼
.7372). Analysis of continuous variables PSV (r2 ¼ 0.159), end-diastolic
velocity (r2 ¼ 0.225), and acceleration time (r2 ¼ 0.081) vs percentage
of CTA stenosis showed poor correlation. These parameters were also
not predictive of stenosis category when analyzed by multivariable logistic
regression.
Conclusions: In the presence of AcS, DUS alone is inadequate to
determine the degree of carotid stenosis. In such circumstances, when the
degree of stenosis would directly affect clinical decision making, CTA is
necessary to adequately characterize the severity of carotid stenosis.
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Objectives: The National Surgical Quality Improvement Program
(NSQIP) universal risk calculator tool was designed using 1.4 million cases
and >1500 unique Current Procedural Terminology (CPT) codes to esti-
mate perioperative risk across multiple surgical subspecialties to guide
informed consent. We aimed to test whether perioperative risk was accu-
rately estimated for a vascular surgery cohort in a community teaching hos-
pital setting.
Methods: We performed an IRB-approved retrospective record re-
view of all consecutive vascular surgery cases between July 1, 2012, and
June 30, 2013. We excluded CPT codes that were not available in the
risk calculator and reoperations #30 days of the index procedure. We
reviewed all 23 preoperative risk factors present in the NSQIP tool for
each procedure. An estimated case-speciﬁc risk for each of 10 predicted
postoperative complications was then calculated using this tool. Using the
Brier Score for statistical analysis, we compared the estimated risk to our
observed postoperative outcomes.
Results: Of 914 consecutive vascular procedures performed in a hos-
pital setting, only 359 procedures met the inclusion criteria. This encom-
passed 51 different CPT codes within vascular surgery. The risk calculator
closely approximated the observed mortality rate and slightly underesti-
mated the observed outcomes in eight of the other 10 outcome categories.
Alternatively, there was noted a greater tendency to underestimate the
observed risk for serious complications. The Brier Scores showed high accu-
racy of prediction with scores #0.16 (Table). (Brier score values are be-
tween 0 and 1, with 0 ¼ perfect accuracy).
Conclusions: The Universal Risk Calculator accurately estimates
surgical outcomes in a vascular-speciﬁc cohort of patients in a commu-
nity teaching hospital setting. Although not perfect, the risk calculator
predicts complication rates well enough for its intended purpose of
helping guide the informed consent discussions with patients. Studies
with large vascular patient cohorts may be necessary to more accurately
evaluate this tool, especially with respect to more serious complications,
and/or to create a more comprehensive one speciﬁc to vascular
patients.culator to mean observed outcomes in our cohort
iac
r MI) SSI UTI VTE
Renal
failure Return to OR
Serious
complication
7 2.24 1.41 0.99 1.13 7.92 12.35
6 4.46 2.51 0.84 1.95 9.75 20.89
4 0.04 0.01 0.01 0.02 0.09 0.15
, urinary tract infection; VTE, venous thromboembolism.
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